How do you approach a patient with cN0 breast cancer who has high risk features but did not have a sentinel node biopsy?

For T1 and T2 disease, I usually treat levels 1 and 2 in tangent beams.

This is not a frequent scenario in my practice. While routine omission of SLN Bx is increasingly considered for elderly women with hormone-positive breast cancer based on the SSO choosing wisely criteria, there are some data suggesting that this is most appropriate in select scenarios (T1a-c grade 1...